Therapeutic Resolution of Pulmonary Arterial Hypertension (PAH) Using Natural Products
Targets · 02.12.2024 · 2 (4) · 428-445
DOI: 10.3390/targets2040024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Targets, online erschienen am 02.12.2024. Verfasst von Maria Osei-Wusuansa und 10 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GrowMedtech, Royal Society, Commonwealth Scholarship Commission (CSC).
Abstract (Originalsprache)
Pulmonary arterial hypertension (PAH) is a progressive and rare condition characterised by the occlusion of pulmonary arterioles, with clinical manifestations resulting from the cross-sectional area reduction of the small pulmonary arteries. The disease is driven by a combination of factors including vasoconstriction, thrombosis, inflammation, proliferation, and the obstructive remodelling of the pulmonary artery walls. Heterozygous mutations in the type II bone morphogenetic protein receptor (BMPR2) underlie the majority of the inherited and familial forms of PAH. Current evidence indicates that in PAH, the BMPR2-mediated-signalling is diminished and the TGFβ signalling is heightened. Even when managed with current therapeutic approaches, the disease eventually results in increased pulmonary vascular resistance, right heart failure, and premature death. Natural products act as vascular disease treatment agents and have been used in clinical practice following compelling clinical trials. The rationale for the selection of natural compounds derives from their multi-targeted approach and synergistic effects. Although novel medicines licenced by the FDA (USA) between 1981 and 2010, constitute approximately 34% natural products or derivatives of natural products, their potentials for the treatment of PAH are not fully explored. The objective of this review is to emphasise the significance of natural products in the therapeutic resolution of PAH.
Förderung
- GrowMedtech
- Royal Society
- Commonwealth Scholarship Commission (CSC)
- University of Bradford (UoB)
- Ghana Scholarship Secretariat
Zitieren
APA
Osei-Wusuansa, M., Mohammed, N., Makanjuola, D., Habas, K., Sener, S. O., Assi, K. H., Nasim, R., Nawaz, S., Gopalan, R. C., Wright, C. W., & Nasim, M. T. (2024). Therapeutic Resolution of Pulmonary Arterial Hypertension (PAH) Using Natural Products. Targets, 2(4), 428-445. https://doi.org/10.3390/targets2040024
Vancouver
Osei-Wusuansa M, Mohammed N, Makanjuola D, Habas K, Sener SO, Assi KH, et al. Therapeutic Resolution of Pulmonary Arterial Hypertension (PAH) Using Natural Products. Targets. 2024;2(4):428-445. doi:10.3390/targets2040024
BibTeX
@article{OseiWusuansa2024,
author = {Osei-Wusuansa, Maria and Mohammed, Nura and Makanjuola, Damilola and Habas, Khaled and Sener, Sila Ozlem and Assi, Khaled H. and Nasim, Rateep and Nawaz, Sadaf and Gopalan, Rajendran C. and Wright, Colin W. and Nasim, M. Talat},
title = {Therapeutic Resolution of Pulmonary Arterial Hypertension (PAH) Using Natural Products},
journal = {Targets},
year = {2024},
volume = {2},
number = {4},
pages = {428--445},
doi = {10.3390/targets2040024}
}
EUVIMED